BUKU BASA INDIA KAKAIT KARO «व्याहित»
Temukaké kagunané saka
व्याहित ing pilihan bibliografi iki. Buku kang kakait dening
व्याहित lan pethikan cekak kang padha kanggo nyediyakaké panggunané ing sastra Basa India.
1
Management of Lipids in Clinical Practice - Page 188
Third, the VA-HIT population was older and included more diabetic patients. Fourth, approximately 2% of the placebo group and 1% of the gemfibrozil group were given open-label lipid medication in the VA-HIT, whereas in the BIP study, 15% ...
Neil J. Stone, Conrad B. Blum, 2008
2
Peripheral Vascular Disease: Basic Diagnostic and ... - Page 86
The Veterans Administration HDL Intervention Trial (VA-HIT) enrolled 2,531 men with known CHD, low HDL-C, and normal LDL-C levels; approximately 25% of the men who fit these entry criteria had diabetes, whereas 50% had either type 2 ...
3
Triglycerides and Cholesterol Research - Page 10
Results from the VA-HIT. Cox regression analysis for the hazard ratios (HR) as calculated for each 1 mg/dl increase in o-1 and HDL-C levels in predicting subsequent cardiovascular events (n=398) in VA-HIT (n=1495). HR for each 1 mg/dl ...
4
Comprehensive Cardiovascular Medicine in the Primary Care ...
VA-HIT, 769 diabetics with known heart disease were randomized to either placebo or gemfibrozil 1,200 mg daily for 5 years. Baseline LDL-cholesterol and triglyceride levels were similar to those seen in the FIELD trial while HDL-cholesterol ...
Peter P. Toth, Christopher P. Cannon, 2010
5
Atherosclerosis: Molecular and Cellular Mechanisms - Page 113
Fibrate treatment reduced the incidence of coronary heart disease in both the HHS [89] and VA-HIT trials [93]. Of note, BIP and VA-HIT subjects were not on statins, LDL-cholesterol-lowering drugs. Altogether, results from these three studies ...
Sarah Jane George, Jason Johnson, 2010
6
Atherosclerosis: Diet and Drugs - Page 547
Gemfibrozil also produced a significant increase in HDL3-C in the secondary prevention trial VA-HIT which was related to a reduction of CHD events (Robins et al. 2001). VA-HIT selected men with low HDL-C levels (average 0.82 mmol/l) and ...
Arnold von Eckardstein, 2006
7
Comprehensive Management of High Risk Cardiovascular Patients
Prior to the FIELD study, the VA-HIT provided the largest sample of diabetic patients treated with a fibric acid derivative. In VA-HIT, 769 diabetics with known heart disease were randomized either placebo or gemfibrozil 1200 mg daily for five ...
Antonio M. Gotto, Peter P. Toth, 2006
8
Cardiovascular Therapeutics: A Companion to Braunwald's ...
In patients with CHD and low HDL, the Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (VA-HIT) study31 shows that gemfibrozil compares favorably with statin therapy, using a number needed to treat (NNT) to prevent ...
9
Landmark Papers in Cardiovascular Medicine - Page 37
Veterans. Administration. HDL. Intervention. Trial. (VA-HIT). Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB. Gemfibrozil for the secondary prevention of coronary heart disease in men With low levels of high-density ...
Aung Myat, A. H. Gershlick, Tony Gershlick, 2012
10
Peroxisome Proliferator Activated Receptors: From Basic ... - Page 85
Perhaps most intriguing is the possibility that the benefits seen in the HDL Intervention Trial (VA-HIT) [35] were in fact due to gemfibrozil activity on PPARa as opposed to, or in conjunction with, its lipid effects [36]. VA-HIT investigators asked if ...
J.-C. Fruchart, Antonio M. Gotto Jr., Rodolfo Paoletti, 2002
